Majken Westergaard

1.2k total citations
14 papers, 1.0k citations indexed

About

Majken Westergaard is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Majken Westergaard has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Pharmacology. Recurrent topics in Majken Westergaard's work include NF-κB Signaling Pathways (3 papers), RNA Interference and Gene Delivery (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Majken Westergaard is often cited by papers focused on NF-κB Signaling Pathways (3 papers), RNA Interference and Gene Delivery (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Majken Westergaard collaborates with scholars based in Denmark, Poland and United States. Majken Westergaard's co-authors include Karsten Kristiansen, Knud Kragballe, Lars Iversen, J. Henningsen, Henrik Daa Schrøder, Claus Johansen, Lars Bolund, Henrik Ørum, Uffe Birk Jensen and Puja Sapra and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemistry.

In The Last Decade

Majken Westergaard

14 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Majken Westergaard Denmark 11 708 310 244 185 106 14 1.0k
Ye Jin Jang South Korea 13 617 0.9× 328 1.1× 237 1.0× 205 1.1× 36 0.3× 15 1.1k
Antonia Livolsi France 10 758 1.1× 697 2.2× 502 2.1× 254 1.4× 30 0.3× 11 1.3k
Horacio Martinetto Argentina 13 879 1.2× 219 0.7× 155 0.6× 233 1.3× 27 0.3× 33 1.1k
Lidia Avalle Italy 17 519 0.7× 217 0.7× 413 1.7× 491 2.7× 67 0.6× 25 1.1k
Adriana Radler‐Pohl Germany 12 719 1.0× 200 0.6× 109 0.4× 256 1.4× 156 1.5× 15 979
F. Christopher Zusi United States 13 561 0.8× 373 1.2× 296 1.2× 217 1.2× 17 0.2× 19 1.0k
Mariusz L. Hartman Poland 17 713 1.0× 185 0.6× 161 0.7× 249 1.3× 51 0.5× 36 990
Luowei Li United States 18 852 1.2× 103 0.3× 118 0.5× 199 1.1× 77 0.7× 29 1.2k
Marta Martínez Spain 16 717 1.0× 299 1.0× 177 0.7× 262 1.4× 17 0.2× 28 1.2k
Yongxin Zou China 21 1.2k 1.7× 363 1.2× 184 0.8× 269 1.5× 20 0.2× 54 1.5k

Countries citing papers authored by Majken Westergaard

Since Specialization
Citations

This map shows the geographic impact of Majken Westergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Majken Westergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Majken Westergaard more than expected).

Fields of papers citing papers by Majken Westergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Majken Westergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Majken Westergaard. The network helps show where Majken Westergaard may publish in the future.

Co-authorship network of co-authors of Majken Westergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Majken Westergaard. A scholar is included among the top collaborators of Majken Westergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Majken Westergaard. Majken Westergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Greenberger, Lee M., Ivan D. Horak, David Filpula, et al.. (2008). A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth. Molecular Cancer Therapeutics. 7(11). 3598–3608. 199 indexed citations
2.
Hansen, Jens Bo, Niels Fisker, Majken Westergaard, et al.. (2008). SPC3042: a proapoptotic survivin inhibitor. Molecular Cancer Therapeutics. 7(9). 2736–2745. 73 indexed citations
3.
Fisker, Niels, Majken Westergaard, Henrik F. Hansen, & Jens Bo Hansen. (2007). Survivin mRNA Antagonists Using Locked Nucleic Acid, Potential for Molecular Cancer Therapy. Nucleosides Nucleotides & Nucleic Acids. 26(10-12). 1427–1430. 11 indexed citations
4.
Westergaard, Majken, Henrik F. Hansen, Charlotte Albæk Thrue, et al.. (2006). SPC2968—A novel Hif-1α antagonist for treatment of clear cell renal cell carcinoma. Journal of Clinical Oncology. 24(18_suppl). 14581–14581. 1 indexed citations
5.
Johansen, Claus, Esben N. Flindt, Knud Kragballe, et al.. (2005). Inverse Regulation of the Nuclear Factor-κB Binding to the p53 and Interleukin-8 κB Response Elements in Lesional Psoriatic Skin. Journal of Investigative Dermatology. 124(6). 1284–1292. 53 indexed citations
6.
Johansen, Claus, Knud Kragballe, Majken Westergaard, et al.. (2005). The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. British Journal of Dermatology. 152(1). 37–42. 177 indexed citations
7.
Kearney, Phil, Majken Westergaard, Jens Bo Hansen, et al.. (2005). SPC2996 - A New Bcl-2 Inhibitor for the Treatment of CLL.. Blood. 106(11). 2984–2984. 1 indexed citations
8.
Westergaard, Majken, J. Henningsen, Karsten Kristiansen, et al.. (2003). Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin. Journal of Investigative Dermatology. 121(5). 1104–1117. 97 indexed citations
9.
Hansen, Jens Bo, Majken Westergaard, Charlotte Albæk Thrue, Birgit Giwercman, & Henrik Oerum. (2003). Antisense Knockdown of PKC-α Using LNA-Oligos. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 1607–1609. 12 indexed citations
10.
Hansen, Jens, Peter Bross, Majken Westergaard, et al.. (2003). Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter. Human Genetics. 112(1). 71–77. 109 indexed citations
11.
Hansen, Jens Jacob, Peter Bross, Majken Westergaard, et al.. (2003). Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter. Human Genetics. 112(4). 436–436. 8 indexed citations
12.
Westergaard, Majken, J. Henningsen, Irina Kratchmarova, et al.. (2001). Modulation of Keratinocyte Gene Expression and Differentiation by PPAR-Selective Ligands and Tetradecylthioacetic Acid. Journal of Investigative Dermatology. 116(5). 702–712. 203 indexed citations
13.
Elsea, Sarah H., Majken Westergaard, D. Andrew Burden, Jefferson P. Lomenick, & Neil Osheroff. (1997). Quinolones Share a Common Interaction Domain on Topoisomerase II with Other DNA Cleavage-Enhancing Antineoplastic Drugs. Biochemistry. 36(10). 2919–2924. 35 indexed citations
14.
Osheroff, Neil, Anita H. Corbett, Sarah H. Elsea, & Majken Westergaard. (1994). Defining functional drug-interaction domains on topoisomerase II by exploiting mechanistic differences between drug classes. Cancer Chemotherapy and Pharmacology. 34(S1). S19–S25. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026